Browsing Category
Pharma Industry News
4743 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Blood test for 10 cancers enters large-scale trial stage in UK, backed by Proteotype and NHS
ENLIGHTEN, a UK-developed blood test that detects up to 10 cancers early, reaches key trial milestone with 450+ participants; Proteotype Diagnostics leads effort.
What makes molecular clamp technology attractive for future combination respiratory vaccines?
Can molecular clamp technology make combination respiratory vaccines more practical than mRNA? Learn how Sanofi plans to use it for multi-pathogen protection.
Can Jagsonpal Pharmaceuticals’ dermatology push turn into a breakout growth segment?
Jagsonpal Pharmaceuticals is expanding its dermatology portfolio, aiming to turn anti-fungal and skin-care therapies into its next big growth driver in India.
Alamar Biosciences and DZNE partner to profile 23,000 samples in landmark neurodegeneration biomarker study
Alamar Biosciences partners with DZNE to deploy its NULISAseq panels in the Rhineland Study, profiling 23,000 plasma samples for aging and dementia biomarker discovery.
Is Sanofi creating a template for biopharma bolt-on deals with its Vicebio acquisition?
Is Sanofi setting a new standard for biopharma bolt-on deals with its $1.15B Vicebio acquisition? Find out how this strategy could shape future M&A.
Is Jagsonpal Pharmaceuticals’ asset-light model a blueprint for mid-cap pharma growth in India?
Jagsonpal Pharmaceuticals’ asset-light model, zero-debt balance sheet, and 23% ROE show how mid-cap Indian pharma firms can grow without heavy capex.
Qynapse unveils QyPredict and QyScore data for early Alzheimer’s detection at AAIC 2025
Qynapse’s QyPredict and QyScore platforms show high accuracy and predictive power in preclinical Alzheimer’s at AAIC 2025, boosting clinical trial efficiency.
Will Vicebio’s VXB-241 and VXB-251 give Sanofi an edge in older adult respiratory protection?
Can Sanofi’s VXB-241 and VXB-251 vaccines protect older adults better than single-pathogen RSV shots? Explore how they could reshape respiratory care.
Can Jagsonpal Pharmaceuticals’ gynae leadership give it an edge as women’s health awareness surges in India?
Jagsonpal Pharmaceuticals’ 90% gynaecologist reach and #7 CVM rank boost its edge as demand for hormone therapies and progesterone products grows in India.
Bayer’s FDA review extension for elinzanetant signals global push for hormone-free menopause therapies
Bayer receives FDA review extension for elinzanetant menopause drug; U.S. approval still likely, with global rollout underway and analysts optimistic.